Switching Anticoagulants and Managing Complexity in Frail Patients With Atrial Fibrillation

Giulio Francesco Romiti; Professor Gregory Lip

doi:10.1016/j.jacc.2025.06.020

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2022

Direct Oral Anticoagulants in Old and Frail Patients with Atrial Fibrillation: The Advantages of an Anticoagulation Service

Maria Cristina Vedovati, Giancarlo Agnelli

Article2020

Oral anticoagulants for nonvalvular atrial fibrillation in frail elderly patients: insights from the ARISTOPHANES study

Professor Gregory Lip, Allison Keshishian, Amiee Kang, Amol D. Dhamane, Xuemei Luo, X. Li, N. Balachander, Lisa Rosenblatt, Jack Mardekian, Xiangbin Pan, Manuela Di Fusco, Alessandra Bassalobre García, Hüseyin Yüce, Steve Deitelzweig

Article2019

COMPARATIVE EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS AMONG FRAIL NONVALVULAR ATRIAL FIBRILLATION PATIENTS

Professor Gregory Lip, Allison Keshishian, Amiee Kang, Amol D. Dhamane, Xuemei Luo, Xiaoyan Li, Neeraja Balachander, Lisa Rosenblatt, Jack Mardekian, Xianying Pan, Manuela Di Fusco, Alessandra Bassalobre García, Hüseyin Yüce, Steven Deitelzweig

Article2023

Managing high-risk atrial fibrillation patients with multiple comorbidities

Professor Gregory Lip

Article2019

Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Disease

So-Ryoung Lee, Hyun‐Jung Lee, Eue-Keun Choi, Kyungdo Han, Jin‐Hyung Jung, Myung‐Jin Cha, Seil Oh, Professor Gregory Lip